Education
About Us
Working with TipRanks
Follow Us
Galectin Therapeutics (GALT) (GALT)
:GALT
Galectin Therapeutics (GALT) Ownership Overview
28.02% Insiders
4.70% Mutual Funds
12.54% Other Institutional Investors
4.47% ETFs
50.27% Public Companies and
Individual Investors
The ownership structure of Galectin Therapeutics (GALT) stock is a mix of institutional, retail, and individual investors. Approximately 21.71% of the company’s stock is owned by Institutional Investors, 28.02% is owned by Insiders, and 50.27% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 31, 2024 | Harold Shlevin Director | xxxxxxxxxxxxx | $7540 |
| Dec 26, 2024 | Richard A. Jr. Zordani Director | xxxxxxxxxxxxx | $8100 |
| Dec 26, 2024 | Kevin D. Freeman Director | xxxxxxxxxxxxx | $8100 |
| Dec 26, 2024 | Kary Eldred Director | xxxxxxxxxxxxx | $11045 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 10,328,981 | Insider | 16.58% | 17,352,688 | |
| 5,922,207 | Insider | 9.50% | 9,949,308 | |
| 2,025,821 | Institution | 3.25% | 3,403,379 | |
| 1,917,722 | Institution | 3.08% | 3,221,773 | |
| 834,592 | Insider | 1.34% | 1,402,115 | |
| 608,789 | Institution | 0.98% | 1,022,766 | |
| 497,998 | Institution | 0.80% | 836,637 | |
| 212,302 | Institution | 0.34% | 356,667 | |
| 142,832 | Insider | 0.23% | 239,958 | |
| 112,269 | Institution | 0.18% | 188,612 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,917,722 | Institution | 3.08% | 3,221,773 | |
| 497,998 | Institution | 0.80% | 836,637 | |
| 212,302 | Institution | 0.34% | 356,667 | |
| 112,269 | Institution | 0.18% | 188,612 | |
| 65,073 | Institution | 0.10% | 109,323 | |
| 37,318 | Institution | 0.06% | 62,694 | |
| 27,623 | Institution | 0.04% | 46,407 | |
| 26,902 | Institution | 0.04% | 45,195 | |
| 10,087 | Institution | 0.02% | 16,946 | |
| 7,500 | Institution | 0.01% | 12,600 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,247,562 | Institution | 2.00% | 1,559,453 | |
| 670,160 | Institution | 1.08% | 837,700 | |
| 386,321 | Institution | 0.62% | 649,019 | |
| 105,828 | Institution | 0.17% | 177,791 | |
| 90,850 | Institution | 0.15% | 113,563 | |
| 79,074 | Institution | 0.13% | 98,843 | |
| 70,685 | Institution | 0.11% | 118,751 | |
| 53,742 | Institution | 0.09% | 94,586 | |
| 45,955 | Institution | 0.07% | 77,204 | |
| 12,013 | Institution | 0.02% | 21,143 |
FAQ
Who Owns Galectin Therapeutics (GALT) (GALT)?
According to the latest TipRanks data, approximately 12.54% of the company's stock is held by institutional investors, 28.02% is held by insiders, and 50.27% is held by retail investors.
What percentage of Galectin Therapeutics (GALT) (GALT) stock is held by institutional investors?
According to the latest TipRanks data, approximately 12.54% of Galectin Therapeutics (GALT) (GALT) stock is held by institutional investors.
What percentage of Galectin Therapeutics (GALT) (GALT) stock is held by retail investors?
According to the latest TipRanks data, approximately 50.27% of Galectin Therapeutics (GALT) (GALT) stock is held by retail investors.
Who owns the most shares of Galectin Therapeutics (GALT) (GALT)?
Richard E Uihlein owns the most shares of Galectin Therapeutics (GALT) (GALT).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.